Related Experiment Video
Updated: Feb 28, 2026

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
Published on: June 10, 2015
Beyond Blood Pressure: Salt Sensitivity as a Cardiorenal Phenotype-A Narrative Review
Maria Bachlitzanaki1, Georgios Aletras2,3, Eirini Bachlitzanaki2
1Department of Internal Medicine, Venizelio General Hospital of Heraklion, 71409 Heraklion, Greece.
Salt-sensitive blood pressure (SSBP) involves abnormal sodium handling, impacting kidneys and heart. Early recognition and tailored treatments, including medications and lifestyle changes, can improve cardiorenal outcomes in this hypertensive phenotype.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Hypertension Research
Background:
- Salt-sensitive blood pressure (SSBP) is an underrecognized hypertensive phenotype where blood pressure and volume status are heavily influenced by dietary sodium.
- It involves complex interactions of renal sodium handling, neurohormonal activation, vascular dysfunction, and inflammation, contributing to kidney injury and cardiac remodeling.
- SSBP is linked to chronic kidney disease (CKD) and heart failure with preserved ejection fraction (HFpEF), highlighting its clinical significance.
Purpose of the Study:
- To review current mechanistic and clinical evidence on SSBP.
- To focus on pathophysiology, cardiorenal interactions, diagnostic challenges, and practical, phenotype-guided therapeutic strategies.
Main Methods:
- A narrative literature review was performed using major scientific databases (PubMed, Scopus, Web of Science).
- Integration of experimental, translational, and clinical studies, alongside guideline documents, for comprehensive interpretation.
Main Results:
- Key mechanisms include impaired renal sodium excretion, intrarenal RAAS activation, sympathetic overactivity, endothelial dysfunction, and inflammation, affecting the kidney-heart axis.
- Clinical manifestations include non-dipping BP, albuminuria, edema, and predisposition to HFpEF.
- Dynamic BP monitoring and targeted lab assessments aid in identifying SSBP and guiding management.
Conclusions:
- Early identification of SSBP allows for interventions beyond general sodium restriction.
- Phenotype-guided therapies, including lifestyle changes and specific drug classes (RAAS blockade, diuretics, MRAs, SGLT2i), may enhance cardiorenal outcomes.
- Emerging technologies for BP and sodium monitoring show promise for personalized management.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Diuretics

